As we enter 2021, the biotech industry is already bustling with activity. There were many memorable moments for the European biotech industry in 2020. The Covid-19 pandemic took over the media and many biotech companies changed their focus to develop vaccines, treatments, and diagnostics for the novel disease. Others were busy in the background with impressive funding rounds, marketing authorizations, and exciting trial results.
The full list of 21 European biotech companies likely to make a big splash in the biotechnology sector over the next year, including Chesterford Research Park based NodThera, can be found here.